Rizwana F. Sproule, VP Regulatory Affairs at Kite Pharma, Inc. (KITE), sold 9,567 shares at $50.49 ($480K) on 2015-05-15, disclosed to the SEC on 2015-05-19.
Scheduled sale ($480k) by VP Regulatory Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.47 | 5,186 | $257K | 53.5% |
| 2 | $50.49 | 2,538 | $128K | 26.7% |
| 3 | $51.63 | 1,813 | $94K | 19.5% |
| 4 | $52.21 | 30 | $2K | 0.3% |
| Total | $50.16 avg | 9,567 | $480K | 100% |
| Filing → |
| KITE | SELL | 2016-01-19 | $531K | — | Filing → |
| KITE | SELL | 2015-12-17 | $610K | — | Filing → |
| KITE | SELL | 2015-11-18 | $748K | — | Filing → |